Revenue Breakdown
Composition ()
No data
Revenue Streams
Henry Schein Inc (HSIC) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Global distribution and ValueAdded services, accounting for 84.9% of total sales, equivalent to $2.83B. Other significant revenue streams include Global Speciality Products and Global Technology. Understanding this composition is critical for investors evaluating how HSIC navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Henry Schein Inc maintains a gross margin of 28.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 6.02%, while the net margin is 3.26%. These profitability ratios, combined with a Return on Equity (ROE) of 11.39%, provide a clear picture of how effectively HSIC converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, HSIC competes directly with industry leaders such as OLPX and RDGT. With a market capitalization of $8.74B, it holds a leading position in the sector. When comparing efficiency, HSIC's gross margin of 28.69% stands against OLPX's 60.21% and RDGT's 20.51%. Such benchmarking helps identify whether Henry Schein Inc is trading at a premium or discount relative to its financial performance.
